Cite

HARVARD Citation

    Lopez, N. et al. (n.d.). P394 Preoperative serum vedolizumab levels do not predict postoperative outcomes in inflammatory bowel disease (IBD). Journal of Crohn's and colitis. pp. S303-S304. [Online]. 
  
Back to record